Emerson Padiernos

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer”.

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100007

N/A

5.6DataRank · unranked

182 citations

Anna‐Leigh Brown, Jun S. Wei, Svetlana Pack, Christopher Trindade, Chul Kim +26 more

Orbital metastases from malignant mesothelioma

The Lancet Oncology(2020)10.1016/s1470-2045(19)30822-8

N/A

0DataRank · unranked

1 citations

Emerson Padiernos, Raffit Hassan, Azam Ghafoor, Idrees Mian

Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9054

N/A

0DataRank · unranked

22 citations

Idrees Mian, Cathy Wagner, Yvonne Mallory, Maria Agra, Emerson Padiernos +8 more